Chimera Investment 株価情報 (NYSE: CIM)

Chimera Investment (NYSE:CIM) 株価情報

Chimera Investment

Chimera Investment Corporation is a real estate investment trust engaged in investing in a portfolio of mortgage assets on a leveraged basis. These investments include a variety of government-sponsored agency residential mortgage-backed securities, or RMBS, non-agency RMBS, agency commercial mortgage-backed securities, residential mortgage loans, and other real estate-related securities. Agency mortgage-backed securities represent the share of this portfolio, while subprime residential mortgage loans and non-agency RMBS also make up substantial shares.

Chimera Investment Corporation Common Stock

Chimera Investment Corp

CIMB GROUP HLDGS BHD ORD by CIMB Group Holdings BHD

CIMB Group Holdings Bhd

CIMC ENRIC HLDGS LTD ORD by CIMC Enric Holdings Ltd.

CIMC Enric Holdings Ltd

Chimera Investment Corporation 9.000% Senior Notes due 2029

Chimera Investment Corporation 9.250% Senior Notes due 2029

CIMAREX ENERGY 8 1/8 PFD by Cimarex Energy Co.

Chimera Investment Corporation 8.00% Series A Cumulative Redeemable Preferred Stock

Chimera Investment Corporation 8.00% Series B Fixed-to-Floating Rate Cumulative Redeemable Preferred Stock

Chimera Investment Corporation 7.75% Series C Fixed-to-Floating Rate Cumulative Redeemable Preferred Stock

Chimera Investment Corporation 8.00% Series D Fixed-to-Floating Rate Cumulative Redeemable Preferred Stock

A hotter-than-expected inflation report initially rattled markets on Wednesday morning, but investors found confidence to buy the dip, helping major indexes recover most losses by <a href="https://www.benzinga.com/government/regulations/25/02/43656846/inflation-rises-more-than-expected-in-january-chills-interest-rate-cut-hopes">midday trading in New York.</a>
The S&amp;P 500 was down 0.2%, while the Nasdaq 100 was flat, both rebounding from sharp declines following the January Consumer Price Index report. Small-cap stocks underperformed, with the Russell 2000 slipping 0.8%.
The headline CPI rose 3% year over year in January, surpassing both December's 2.9% reading and economist forecasts of 2.9%. On a monthly basis, inflation increased 0.5%, outpacing expectations of 0.3% and accelerating from December's 0.4% gain. This marked the fastest monthly inflation rate since August 2023.
Core inflation, which excludes food and energy, climbed to 3.3% year over year from 3.2% in December. On a monthly basis, core CPI increased 0.4%, exceeding estimates of 0.3% and doubling December's 0.2% rise.
Treasuries and interest rate markets reacted sharply to the inflation data. Traders scaled back expectations for Federal Reserve rate cuts, now projecting only one reduction by December 2025.
Treasury yields surged, reflecting heightened investor uncertainty. The 10-year Treasury yield jumped 10 basis points to 4.64%. The iShares 20+ Year Treasury Bond ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TLT#NASDAQ">TLT</a>) fell 1%.
Despite rising Treasury yields and a stronger dollar, gold edged up 0.2% to $2,910 per ounce. Oil prices dropped 2% after reports that Donald Trump spoke with Russian President Vladimir Putin, fueling speculation about a potential ceasefire in Ukraine.
Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) also rebounded from earlier session losses.
<h3 class="wp-block-heading">Wednesday&#8217;s Performance In Major US Indices, ETFs</h3>
<figure class="wp-block-table is-style-stripes"> 
<table>
<tbody>
<tr>
<td>Major Indices</td>
<td>Price</td>
<td>1-day %chg</td>
</tr>
<tr>
<td>Nasdaq 100</td>
<td>21,688.40</td>
<td>0.0%</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>6,056.85</td>
<td>-0.2%</td>
</tr>
<tr>
<td>Dow Jones</td>
<td>44,411.00</td>
<td>-0.4%</td>
</tr>
<tr>
<td>Russell 2000</td>
<td>2,257.59</td>
<td>-0.8%</td>
</tr>
</tbody>
</table>
<figcaption class="wp-element-caption">Updated at 12:45 p.m. ET</figcaption></figure>
According to&nbsp;<a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent020325&amp;t=be2bearmibe3na1" target="_blank" rel="noreferrer noopener">Benzinga Pro</a>&nbsp;data:
<ul>
<li>The&nbsp;SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>)&nbsp;inched 0.2% down to $603.77.</li>
<li>The&nbsp;SPDR Dow Jones Industrial Average&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DIA#NYSE">DIA</a>) was 0.4% down to $444.41.</li>
<li>The tech-heavy&nbsp;Invesco QQQ Trust Series&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>)&nbsp;flattened at $528.09.</li>
<li>The&nbsp;iShares Russell 2000 ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IWM#NYSE">IWM</a>) eased 0.8% to $224.</li>
<li>The&nbsp;Consumer Discretionary Select Sector SPDR Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLY#NYSE">XLY</a>) outperformed, up 0.4%; the&nbsp;Energy Select Sector SPDR Fund&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLE#NYSE">XLE</a>) lagged, down 1.2%.</li>
</ul>
Wednesday&#8217;s Stock Movers
<ul>
<li>Tesla Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) jumped more than 4% after the electric vehicle maker tumbled 6.3% on Tuesday, reaching oversold levels and extending its losing streak to five consecutive sessions.</li>
</ul>
Stocks reacting to company earnings reports included: 
<ul>
<li>CVS Health Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVS#NYSE">CVS</a>): up 15.7%</li>
<li>Super Micro Computer Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMCI#NASDAQ">SMCI</a>): up 4.5%</li>
<li>Edwards Lifesciences Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EW#NYSE">EW</a>): up 5.6%</li>
<li>América Móvil, S.A.B. de C.V. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AMX#NYSE">AMX</a>): down 1.4%</li>
<li>American International Group Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AIG#NYSE">AIG</a>): up 0.2%</li>
<li>Energy Transfer LP (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ET#NYSE">ET</a>): up 0.3%</li>
<li>Southern Copper Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SCCO#NYSE">SCCO</a>): up 2.9%</li>
<li>Gilead Sciences Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GILD#NASDAQ">GILD</a>): up 6.8%</li>
<li>Zillow Group Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/Z#NASDAQ">Z</a>): down 10.2%</li>
<li>CME Group Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CME#NASDAQ">CME</a>): up 2.2%</li>
<li>Chimera Investment Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CIM#NYSE">CIM</a>): down 8.9%</li>
<li>Ryder System Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/R#NYSE">R</a>): up 4.0%</li>
<li>Smurfit WestRock Plc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SW#NYSE">SW</a>): down 5.8%</li>
<li>Sonic Automotive Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SAH#NYSE">SAH</a>): down 2.4%</li>
<li>Alkermes Plc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALKS#NASDAQ">ALKS</a>): up 4.1%</li>
<li>Anavex Life Sciences Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVXL#NASDAQ">AVXL</a>): up 1.0%</li>
<li>Biogen Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BIIB#NASDAQ">BIIB</a>): down 4.6%</li>
<li>Blackstone Mortgage Trust Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BXMT#NYSE">BXMT</a>): up 2.8%</li>
<li>Camtek Ltd/Israel (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CAMT#NASDAQ">CAMT</a>): up 1.5%</li>
<li>Chefs' Warehouse Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CHEF#NASDAQ">CHEF</a>): up 13.0%</li>
<li>Diebold Nixdorf Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DBD#NYSE">DBD</a>): down 3.2%</li>
<li>Dominion Energy Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/D#NYSE">D</a>): up 0.6%</li>
<li>Exelon Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EXC#NASDAQ">EXC</a>): up 0.4%</li>
</ul>
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/25/02/43663963/record-high-egg-prices-drive-inflation-higher-in-january">Record-High Egg Prices Drive Inflation Higher In January</a></li>
</ul>
Illustration created using artificial intelligence via Midjourney.

Equities

Large Cap

Commodities

Economics

Federal Reserve

Markets

Tech

ETFs

$BTC

ALKS

AVXL

BIIB

BXMT

CAMT

CHEF

SPDR Dow Jones Industrial Average ETF Trust

GILD

SCCO

SMCI

iShares Trust Barclays 20+ Year Treasury Bond Fund

TSLA

Select Sector SPDR-Consumer Discretionary

Stocks Trim Losses After Hot Inflation, Bonds Remain Pressured, Tesla Rebounds: What's Driving Markets Wednesday?

WIIM

Chimera Investment shares are trading lower after the company reported Q4 financial results and missed its adjusted EPS and revenue estimates.

Chimera Investment (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CIM#NYSE">CIM</a>) reported quarterly earnings of $0.37 per share which missed the analyst consensus estimate of $0.47 by 21.28 percent. This is a 184.62 percent increase over earnings of $0.13 per share from the same period last year. The company reported quarterly sales of $65.82 million which missed the analyst consensus estimate of $77.55 million by 15.12 percent. This is a 1.81 percent increase over sales of $64.65 million the same period last year.

Earnings

Earnings Misses

News

Chimera Investment Q4 2024 Sales $65.82M Miss $77.55M Estimate

Chimera Investment (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CIM#NYSE">CIM</a>) reported quarterly earnings of $0.37 per share which missed the analyst consensus estimate of $0.47 by 21.28 percent.&nbsp;

Chimera Investment Q4 2024 Adj EPS $0.37 Misses $0.47 Estimate

ACRE

AEIS

AEMD

ALCO

AMWL

ASND

ASPN

ATRC

AYTU

BROS

CGNX

CNCK

CNDT

COOP

CRBG

CRSR

CRWS

CSCO

CTRE

CWST

DENN

EPRT

EQIX

FCPT

FSLY

GAIN

GILT

GLPG

GNRC

GOLD

GROW

HCSG

HOOD

HUBS

IREN

KRNT

MKSI

MLYS

MMLP

NMTC

OPRT

OTLY

PAYC

PEGA

PLMR

PODC

PXLW

PYPD

QDEL

QMCO

QTWO

Earnings Scheduled For February 12, 2025

JMP Securities analyst Aaron Hecht reiterates Chimera Investment (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CIM#NYSE">CIM</a>) from Market Perform to Market Perform.

Reiteration

Analyst Ratings

JMP Securities Reiterates Market Perform on Chimera Investmentto Market Perform

During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a<a href="https://www.benzinga.com/yield-investments"> high dividend payout</a>.
Benzinga readers can review the latest analyst takes on their favorite stocks by visiting <a href="https://www.benzinga.com/analyst-stock-ratings">Analyst Stock Ratings</a> page. Traders can sort through Benzinga's extensive database of analyst ratings, including <a href="https://www.benzinga.com/analyst-ratings/analyst-color/22/09/28888638/exclusive-study-finds-benzinga-analyst-ratings-data-yields-market-beating-strategie">by analyst accuracy</a>.
Below are the ratings of the most accurate analysts for three high-yielding stocks in the financials sector.
<h3 class="wp-block-heading">Apollo Commercial Real Estate Finance, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ARI#NYSE">ARI</a>)</h3>
<ul>
<li>Dividend Yield: 10.81%</li>
<li>UBS analyst Douglas Harter maintained a Neutral rating and cut the price target from $10 to $9.5 on Nov. 15. This analyst has an accuracy rate of 66%.</li>
<li>JP Morgan analyst Richard Shane maintained a Neutral rating and decreased the price target from $9.5 to $8.5 on Oct. 17. This analyst has an accuracy rate of 69%.</li>
<li>Recent News: On Oct. 30, the company reported a quarterly loss of 69 cents per share which missed the analyst consensus estimate of a loss of 42 cents per share.</li>
<li>Benzinga Pro's real-time newsfeed alerted to latest ARI news </li>
</ul>
<figure class="wp-block-image size-full is-resized"><img loading="lazy" decoding="async" width="912" height="822" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/02075106/image-1-2.png" alt="" class="wp-image-672246" style="width:569px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/02075106/image-1-2.png 912w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/02075106/image-1-2-300x270.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/02075106/image-1-2-768x692.png 768w" sizes="(max-width: 912px) 100vw, 912px" /></figure>
<h3 class="wp-block-heading">Chimera Investment Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CIM#NYSE">CIM</a>)</h3>
<ul>
<li>Dividend Yield: 9.97%</li>
<li>Keefe, Bruyette &amp; Woods analyst Bose George maintained a Market Perform rating and raised the price target from $15 to $16 on Aug. 8. This analyst has an accuracy rate of 70%.</li>
<li>UBS analyst Douglas Harter initiated coverage on the stock with a Neutral rating and a price target of $16.5 on Dec. 6, 2023. This analyst has an accuracy rate of 66%.</li>
<li>Recent News: On Nov. 6, the company posted downbeat quarterly earnings.</li>
<li>Benzinga Pro's real-time newsfeed alerted to latest CIM news </li>
</ul>
<figure class="wp-block-image size-full is-resized"><img loading="lazy" decoding="async" width="866" height="805" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/02075210/image-6.png" alt="" class="wp-image-672249" style="width:716px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/02075210/image-6.png 866w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/02075210/image-6-300x279.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/02075210/image-6-768x714.png 768w" sizes="(max-width: 866px) 100vw, 866px" /></figure>
<h3 class="wp-block-heading">Starwood Property Trust, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/STWD#NYSE">STWD</a>)</h3>
<ul>
<li>Dividend Yield: 9.43%</li>
<li>UBS analyst Douglas Harter maintained a Neutral rating and increased the price target from $19.5 to $20 on Nov. 15. This analyst has an accuracy rate of 66%.</li>
<li>JMP Securities analyst Steven Delaney maintained a Market Outperform rating and lowered the price target from $24 to $23 on Nov. 7. This analyst has an accuracy rate of 69%.</li>
<li>Recent News: On Nov. 6, the company posted better-than-expected quarterly earnings.</li>
<li>Benzinga Pro&#8217;s charting tool helped identify the trend in STWD stock. </li>
</ul>
<figure class="wp-block-image size-full is-resized"><img loading="lazy" decoding="async" width="907" height="835" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/02075334/image-7.png" alt="" class="wp-image-672253" style="width:665px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/02075334/image-7.png 907w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/02075334/image-7-300x276.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/02075334/image-7-768x707.png 768w" sizes="(max-width: 907px) 100vw, 907px" /></figure>
<figure class="wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio"> 
<div class="wp-block-embed__wrapper">
<iframe loading="lazy" title="How to Find Dividend Stocks: Scan, Analyze, and Capture with Benzinga Pro" width="500" height="281" src="https://www.youtube.com/embed/pVF0O2lsEH4?start=1&#038;feature=oembed" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" referrerpolicy="strict-origin-when-cross-origin" allowfullscreen></iframe>
</div>
</figure>
Read More: 
<ul>
<li><a href="https://www.benzinga.com/24/12/42260979/salesforce-gears-up-for-q3-print-here-are-the-recent-forecast-changes-from-wall-streets-most-accurate-analysts">Salesforce Gears Up For Q3 Print; Here Are The Recent Forecast Changes From Wall Street&#8217;s Most Accurate Analysts</a></li>
</ul>

Price Target

Pre-Market Outlook

Trading Ideas

STWD

Wall Street's Most Accurate Analysts Give Their Take On 3 Financial Stocks Delivering High-Dividend Yields

Chimera Investment (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CIM#NYSE">CIM</a>) reported quarterly earnings of $0.36 per share which missed the analyst consensus estimate of $0.44 by 18.18 percent. The company reported quarterly sales of $66.45 million which missed the analyst consensus estimate of $73.56 million by 9.66 percent. This is a 4.82 percent increase over sales of $63.40 million the same period last year.

Chimera Investment Q3 2024 Adj EPS $0.36 Misses $0.44 Estimate, Sales $66.45M Miss $73.56M Estimate

General

Chimera Investment Says The Palisades Transaction Is Expected To Broaden Chimera's Residential Credit Reach And Be Accretive To Earnings In 2025

Upon closing, Jack Macdowell, Jr., co-founder and Chief Investment Officer of Palisades, will become Chimera's Chief Investment Officer. &nbsp;

Chimera Investment Agreed To Acquire Palisades For $30M In Cash Plus Additional Potential Earnout Of Up To $20M Over Five Years Contingent Upon Achieving Certain Financial Targets, With The Option For Chimera To Pay 50% Of The Earnout Payments In Stock

<ul>
<li>Board Declares Third Quarter 2024 Dividend of $0.37 Per Share of Common Stock</li>
</ul>
The Board of Directors of Chimera Investment Corporation announced the declaration of its third quarter cash dividend of $0.37 per common share. The dividend is payable on October 31, 2024 to common stockholders of record on September 30, 2024. The ex-dividend date is September 30, 2024.
"We are pleased to announce an increase in our common stock dividend for the second consecutive quarter," said Phillip J. Kardis II, President and CEO of Chimera. "We continue to seek opportunities to maximize shareholder value as we enter a more favorable interest rate environment."

Dividends

Chimera Increases Q3 2024 Common Stock Dividend From $0.35 To $0.37 Per Share

Keefe, Bruyette &amp; Woods analyst Bose George maintains Chimera Investment (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CIM#NYSE">CIM</a>) with a Market Perform and raises the price target from $15 to $16.

Keefe, Bruyette & Woods Maintains Market Perform on Chimera Investment, Raises Price Target to $16

Chimera Investment (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CIM#NYSE">CIM</a>) reported quarterly earnings of $0.37 per share which missed the analyst consensus estimate of $0.42 by 11.9 percent. The company reported quarterly sales of $67.295 million which missed the analyst consensus estimate of $71.315 million by 5.64 percent. This is a 2.46 percent increase over sales of $65.678 million the same period last year.

Chimera Investment Q2 2024 Adj. EPS $0.37 Misses $0.42 Estimate, Sales $67.295M Miss $71.315M Estimate

Keefe, Bruyette &amp; Woods analyst Bose George maintains Chimera Investment (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CIM#NYSE">CIM</a>) with a Market Perform and maintains $15 price target.

Keefe, Bruyette & Woods Maintains Market Perform on Chimera Investment, Maintains $15 Price Target

Annaly Capital Management, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/nly#NYSE">NLY</a>) is benefiting from an improvement in the average yield on interest-earning assets. The company&#39;s prudent asset selection will drive its performance. However, the current market volatility and interest rate fluctuations are near-term worries. Additionally, the company&#39;s dividend reduction and an unutilized share repurchase program highlight concerns regarding capital distribution.
NLY&#39;s investment strategy is driven by the prudent selection of assets and effective allocation of capital to achieve stable returns. The company&#39;s investment strategy involves traditional Agency mortgage-backed securities (MBS), which provide downside protection, as well as investments in more non-agency and credit-focused asset classes that aid in enhancing returns. Also, a scaled MSR platform will continue to benefit from a low prepayment environment. As of Mar 31, 2024, its investment portfolio aggregated $87.5 billion.
Further, the company is focused on diversifying its investment portfolio. The company seeks to stabilize and diversify its investment portfolio through investing in Agency MBS and residential credit. NLY&#39;s strong liquidity position enables it to reinvest in the franchise. In 2022, it sold its Middle Market Lending portfolio and exited its commercial real estate business. Through these exits, Annaly was able to enhance capabilities across its core housing finance strategy.
Further, Annaly is focusing on improving its liquidity and reducing leverage. The company showcased a strong liquidity position in the first quarter of 2024. The company maintains an unencumbered asset portfolio, aggregating $5.3 billion, which can readily provide liquidity in times of adverse market conditions. Hence, with a decent balance sheet, the company is well-equipped to support its business, even in times of economic stress and market volatility.
NLY enjoys a diverse funding profile in the industry. Its main sources of financing are repurchasing agreements and various forms of equity. Arcola Securities, its wholly-owned subsidiary, enters repurchase contracts on behalf of the company. This helps it enjoy flexibility in the opportunistic enhancement of its portfolio. Annaly maintains a strong presence in the residential securitization market through its residential credit business. This will enable the company to capitalize on the improving outlook for residential mortgage finance. This will support Annaly&#39;s asset generation strategy.
Shares of Annaly have declined 2.7% over the past six months compared with the industry&#39;s decline of 11.1%.
<img alt="Zacks Investment Research" src="https://staticx-tuner.zacks.com/images/articles/charts/32/70760.jpg?v=435863113" />
Image Source: Zacks Investment Research
At present, Annaly carries a Zacks Rank #3 (Hold).
The operating performances of mREITs depend on conditions prevalent in the broader financial markets and the macroeconomic situation. Any volatility in the mortgage market, unfavorable changes in the shape of the yield curve, interest-rate volatility and deterioration of the generic financial conditions may affect the performance of the company&#39;s investments. The Federal Reserve kept its key interest rate unchanged and scaled back its forecast from three rate cuts to just one this year after an inflation pickup in early 2024. This might not serve as a good indicator for the company.
Annaly&#39;s capital distribution plans keep us apprehensive. In January 2022, it was authorized with a $1.5-billion share repurchase plan, valid through Dec 31, 2024. However, the company has not repurchased shares under this plan since the announcement. Moreover, it slashed its first-quarter 2023 cash dividend by 26% to 65 cents per share due to a moderation in earnings available for distribution. Earlier, amid the pandemic-led market volatility, Annaly slashed its second-quarter 2020 dividends by 12% to 22 cents in June 2020.
<h3>Stocks to Consider:</h3>
A couple of better-ranked stocks are Ellington Credit Company (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/earn#NYSE">EARN</a>) and Chimera Investment Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/cim#NYSE">CIM</a>).
Earnings estimates of Ellington Credit Company have been revised upward by 2% over the past 60 days. In the past six months, EARN&#39;s shares have gained 13.4%. Currently, the company carries a Zacks Rank #1 (Strong Buy).
Earnings estimates for Chimera Investment Corporation have been revised upward by 14.6% for 2024 over the past 60 days. Shares of CIM have gained 6.7% over the past three months. Currently, the company carries a Zacks Rank #2 (Buy).
<a href="https://www.zacks.com/stock/news/2298603/annaly-s-nly-diversification-efforts-aid-amid-market-volatility?cid=CS-BENZ-FT-analyst_blog|zer_report_update-2298603">To read this article on Zacks.com click here.</a>

Small Cap

EARN

Annaly's Diversification Efforts Aid Amid Market Volatility

Chimera Increases Dividend From $0.33 To $0.35

U.S. stock futures were higher this morning, with the Nasdaq futures gaining around 50 points on Monday.
Shares of Seritage Growth Properties (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SRG#NYSE">SRG</a>) fell sharply in today's pre-market trading after the company reported a <a href="https://www.benzinga.com/quote/SRG/earnings">loss for the first quarter</a>.
The company posted a quarterly loss of 36 cents per share, versus a year-ago loss of $1.13 per share, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
Seritage Growth Properties shares dipped 23.6% to $7.12 in pre-market trading.
Here are some big stocks recording losses in today's pre-market trading session.
<ul>
<li>Vitesse Energy, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VTS#NYSE">VTS</a>) shares declined 10.2% to $21.64 in pre-market trading. Vitesse Energy, last week, posted downbeat quarterly earnings.</li>
<li>Chimera Investment Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CIM#NYSE">CIM</a>) shares fell 6.3% to $4.32 in pre-market trading. Chimera Investment announced a 1-for-3 reverse stock split.</li>
<li>Fortrea Holdings Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FTRE#NASDAQ">FTRE</a>) shares declined 6% to $31.06 in pre-market trading after the company reported soft first-quarter results and cut its revenue outlook.</li>
<li>Mesoblast Ltd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MESO#NASDAQ">MESO</a>) shares declined 3.7% to $7.09 in pre-market trading after gaining around 3% on Friday.</li>
<li>Mind Medicine (MindMed) Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MNMD#NASDAQ">MNMD</a>) shares fell 3.7% to $8.92 in pre-market trading.</li>
<li>MKS Instruments Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MKSI#NASDAQ">MKSI</a>) shares declined 3.4% to $126.02 in pre-market trading as the company reported a proposed private offering of $1 billion of convertible senior notes.</li>
<li>Korea Electric Power Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KEP#NYSE">KEP</a>) shares fell 3.3% to $7.29 in pre-market trading after declining 7% on Friday.</li>
<li>PENN Entertainment Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PENN#NASDAQ">PENN</a>) shares slipped 3% to $15.61 in pre-market trading. B of A Securities analyst Shaun Kelley downgraded PENN Entertainment from Buy to Neutral and lowered the price target from $28 to $17.5.</li>
<li>Burford Capital Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BUR#NYSE">BUR</a>) shares slipped 2.5% to $15.05 in pre-market trading after reporting first-quarter results.</li>
</ul>
Now Read This: <a href="https://www.benzinga.com/news/earnings/24/05/38781677/tencent-music-entertainment-stoneco-and-3-stocks-to-watch-heading-into-monday">Tencent Music Entertainment, StoneCo And 3 Stocks To Watch Heading Into Monday</a>
Don't forget to check out our <a href="https://www.benzinga.com/premarket/">premarket coverage here</a>

Movers

FTRE

MESO

MNMD

PENN

Seritage Growth Properties Posts Q1 Loss, Joins Fortrea Holdings And Other Big Stocks Moving Lower In Monday's Pre-Market Session

Stock Split

Chimera Investment Announces 1-For-3 Reverse Stock Split

Chimera Investment (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CIM#NYSE">CIM</a>) reported quarterly earnings of $0.12 per share which missed the analyst consensus estimate of $0.17 by 29.41 percent. The company reported quarterly sales of $65.11 million which missed the analyst consensus estimate of $69.96 million by 6.93 percent. This is a 6.50 percent decrease over sales of $69.64 million the same period last year.

Chimera Investment Q1 2024 Adj EPS $0.12 Misses $0.17 Estimate, Sales $65.11M Miss $69.96M Estimate

Chimera Investment Corporation shares are trading lower after the company reported worse-than-expected Q4 results.

Press Releases

CHIMERA INVESTMENT CORPORATION REPORTS 3RD QUARTER 2024 EARNINGS

Chimera Appoints New Independent Board Member Cynthia B. Walsh

Chimera Investment Corporation Completes Acquisition of Palisades Group

Chimera Declares Fourth Quarter 2024 Common Stock Dividend

Chimera Investment Corporation Announces Date of Fourth Quarter and Full Year 2024 Financial Results and Conference Call

Chimera Investment Corporation Sponsors Residential Mortgage Loan Securitization

Chimera Declares First Quarter 2025 Preferred Stock Dividends

CHIMERA INVESTMENT CORPORATION REPORTS 4TH QUARTER 2024 EARNINGS

Chimera Declares First Quarter 2025 Common Stock Dividend

Chimera Investment Corporation Sponsors Residential Mortgage Loan Securitizations

Comments

Chimera Investment

ニュース

パートナーシップ

ベンジンガ・グローバル